Business Wire

Golub Capital Announces Another Year of “Good Boring” Results: Solid Investor Performance, Strong Deal Activity and Continued Global Expansion in 2024

Share

Golub Capital announced that 2024 was marked by solid investor performance, strong deal activity with private equity sponsors, record fundraising, continued global expansion and growth in its impact philanthropy programs. For Golub Capital, 2024 represented another year of delivering consistent results for its stakeholders, demonstrating the reliability the Firm highlighted in the theme of its annual investor conference: “30 Years of Good Boring.”

“At Golub Capital, we have built our business around the belief that relationships matter, and we seek to strengthen our relationships by delivering so reliably for our partners that it is a bit boring— but in a good way,” said David Golub, President of Golub Capital. “We are pleased that in 2024 we were again successful in serving the needs of our investors, private equity firm clients, other business partners and our team. As we look ahead to the next 30 years and beyond, we are especially thankful to our clients, many of whom we have worked with for decades, for their enduring partnership. We are also excited about where we are headed. Our team, now over 1,000-strong, is well-positioned to keep raising the bar for excellence in private credit.”

2024 Highlights, based on preliminary results:1

Golub Capital provided compelling financing solutions tailored to private equity sponsors’ needs while remaining highly selective.

  • Closed $27.8 billion in financing commitments to existing portfolio companies and new originations across a broad range of transaction sizes and facility types
  • Continued to expand deal activity in Europe, closing $2.5 billion in financing commitments in 2024
  • Was lead lender on approximately 90% of its middle market transactions since 2013

Golub Capital sustained its long track record of low credit losses and attracted record capital from a broad range of investors globally.

  • Delivered strong credit performance, continuing a 20-year track record of average annual payment default rates well below the broadly syndicated loan index2
  • Raised a record $15.5 billion in new investment capital and closed the Firm’s largest Credit Opportunities fund to-date, with $2 billion of investable capital3
  • Executed a record $14.9 billion of securitizations. Golub Capital was the #1 issuer of U.S. middle market CLOs and the #3 issuer of CLOs in the U.S. overall.4

Golub Capital continued to expand its client service capabilities across investor segments and grew its global footprint with a local presence in key international markets.

  • Added senior hires to support the Firm’s growing investor base in Asia and the Middle East; opened a new office in Tokyo; and announced plans to open an office in Abu Dhabi.
  • Expanded in Private Wealth, providing more investors with access to Golub Capital’s private credit expertise. Golub Capital Private Credit Fund (“GCRED”) ended the year with assets over $4 billion.
  • Launched our Insurance Solutions team to enhance our capabilities for insurance companies

Golub Capital further expanded its impact philanthropy programs.

  • Launched the Golub Capital Nonprofit Board Fellows Network with seven leading business schools to prepare MBA candidates and alumni to become impactful nonprofit board members
  • Established the Golub Capital Social Impact Investment Education Fund via a multi-year partnership with the New York University Impact Investment Fund to support students at NYU Stern, NYU Wagner and NYU Abu Dhabi with hands-on experience managing an impact investing fund

About Golub Capital

Golub Capital is a market-leading, award-winning direct lender and experienced private credit manager. We specialize in delivering reliable, creative and compelling financing solutions to companies backed by private equity sponsors. Our sponsor finance expertise also forms the foundation of our Broadly Syndicated Loan and Credit Opportunities investment programs. We nurture long-term, win-win partnerships that inspire repeat business from private equity sponsors and investors.

As of January 1, 2025, Golub Capital had over 1,000 employees and over $75 billion of capital under management, a gross measure of invested capital including leverage. The firm has offices in North America, Europe and Asia. For more information, please visit golubcapital.com.

_______________________

1 Preliminary results are good faith estimates based on available data as of January 6, 2025. Actual data may differ materially from final closing numbers.

2 A loan is classified as a payment default if there is an uncured payment default with respect to principal or interest. The broadly syndicated loan index is represented by the default rate of the Morningstar LSTA US Leveraged Loan Index, measured by principal amount. The Morningstar LSTA US Leveraged Loan Index is a market value-weighted index designed to measure the performance of the U.S. broadly syndicated loan market based upon market weightings, spreads and interest payments. The Morningstar Indexes are the exclusive property of Morningstar, Inc. Morningstar, Inc., its affiliates and subsidiaries, its direct and indirect information providers and any other third party involved in, or related to, compiling, computing or creating any Morningstar Index (collectively, “Morningstar Parties”) do not guarantee the accuracy, completeness and/or timeliness of the Morningstar Indexes or any data included therein and shall have no liability for any errors, omissions, or interruptions therein. None of the Morningstar Parties make any representation or warranty, express or implied, as to the results to be obtained from the use of the Morningstar Indexes or any data included therein.

3 New investment capital reflects equity capital raised by product, multiplied by a product-specific target leverage factor.

4 Source: Creditflux’s “US MM CLO Rankings – FY 2024.” Data as of December 31, 2024.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250115249114/en/

Contacts

Media
press@golubcapital.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release

Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn

Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release

Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of

500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release

500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa

Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release

Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la

Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release

Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye